| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5912732 | Multiple Sclerosis and Related Disorders | 2013 | 7 Pages |
Abstract
Adverse events occur in a minority of Li-treated MS patients. A consistent effect of Li on MS disease activity was not apparent. These findings indicate a clinical trial will be needed to ascertain Li's effects on the MS disease course.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
John R. II, Tiffany C. Cossey, Gary R. Cutter, William J. Culpepper,